Community Research and Development Information Service - CORDIS

Improving Prostate Cancer Outcome with Vectored Vaccines

From 2014-04-01 to 2018-03-31, closed project | IMPROVE Website

Project details

Total cost:

EUR 8 059 818

EU contribution:

EUR 6 000 000

Coordinated in:

United Kingdom

Call for proposal:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 3 336 625


WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD OXFORD
United Kingdom
Activity type: Higher or Secondary Education Establishments
Administrative contact: Stephen Conway
Tel.: +44 1865 289800
Fax: +44 1865 289801
E-mail

Participants

OXFORD BIOMEDICA (UK) LIMITED
United Kingdom

EU contribution: EUR 1 588 375


OXFORD SCIENCE PARK MEDAWAR
OX4 4GA OXFORD
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative contact: Tim Watts
Tel.: +44 1865783000
Fax: +44 1865783001
E-mail
GLAXOSMITHKLINE VACCINES SRL
Italy

EU contribution: EUR 300 000


VIA FIORENTINA 1
53100 SIENA
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative contact: Francesco Gulli
Tel.: +39 0577243089
E-mail
UNIVERSITE DE LAUSANNE
Switzerland

EU contribution: EUR 500 000


Quartier Unil-Centre Bâtiment Unicentre
1015 LAUSANNE
Switzerland
Activity type: Higher or Secondary Education Establishments
Administrative contact: Pedro Romero
Tel.: +41 21 3140198
E-mail
EXTERNAUTICS SPA
Italy

EU contribution: EUR 275 000


VIA FIORENTINA 1
53100 SIENA
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative contact: Paolo Sarmientos
Tel.: +39 0577231287
E-mail

Subjects

Life Sciences
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top